Medibank Private Ltd
ASX:MPL

Watchlist Manager
Medibank Private Ltd Logo
Medibank Private Ltd
ASX:MPL
Watchlist
Price: 4.77 AUD -1.24% Market Closed
Market Cap: 13.1B AUD

Intrinsic Value

The intrinsic value of one MPL stock under the Base Case scenario is 4.52 AUD. Compared to the current market price of 4.77 AUD, Medibank Private Ltd is Overvalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MPL Intrinsic Value
4.52 AUD
Overvaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Medibank Private Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about MPL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MPL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Medibank Private Ltd.

Explain Valuation
Compare MPL to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Medibank’s costly and high-profile 2022 data breach may erode consumer trust in its brand, creating potential churn and putting downward pressure on membership growth.

Stringent regulatory oversight by the Australian government, including restrictions on premium increases and policy benefits, could compress Medibank’s margins and limit pricing power.

Heightened competition from smaller, more agile health insurance providers offering tech-driven solutions and niche coverage could undermine Medibank’s market share over time.

Bull Theses

Medibank’s dominant market share and strong brand recognition position it to capture ongoing industry tailwinds, such as an aging population seeking private health coverage.

The company’s focus on health management and digital wellness initiatives may drive customer engagement, potentially translating into higher retention rates and more stable underwriting results.

Strong balance sheet and consistent free cash flow generation give Medibank flexibility to invest in growth opportunities, healthcare partnerships, and potential acquisitions.

Show More Less
How do you feel about MPL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medibank Private Ltd

Cash & Short-Term Investments 648.6m
Insurance Receivable 66.4m
PP&E 194.2m
Long-Term Investments 3.1B
Other Assets 689.6m
Insurance Policy Liabilities 1.8B
Short Term Debt 35m
Long Term Debt 144.8m
Other Liabilities 430.7m

Wall St
Price Targets

MPL Price Targets Summary
Medibank Private Ltd

Wall Street analysts forecast MPL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MPL is 5.33 AUD with a low forecast of 4.75 AUD and a high forecast of 6.13 AUD.

Lowest
Price Target
4.75 AUD
0% Downside
Average
Price Target
5.33 AUD
12% Upside
Highest
Price Target
6.13 AUD
29% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MPL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

MPL News

Other Videos
What is the Intrinsic Value of one MPL stock?

The intrinsic value of one MPL stock under the Base Case scenario is 4.52 AUD.

Is MPL stock undervalued or overvalued?

Compared to the current market price of 4.77 AUD, Medibank Private Ltd is Overvalued by 5%.

Back to Top